Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeWages, Salaries and Other
Others
Ratios

Sagimet Biosciences (SGMT) Revenue (2023)

Sagimet Biosciences (SGMT) has 1 years of Revenue data on record, last reported at $2.0 million in Q3 2023.

  • For Q3 2023, Revenue changed N/A year-over-year to $2.0 million; the TTM value through Jun 2024 reached $2.0 million, changed N/A, while the annual FY2023 figure was $2.0 million, N/A changed from the prior year.
  • Revenue reached $2.0 million in Q3 2023 per SGMT's latest filing.
  • Across five years, Revenue topped out at $2.0 million in Q3 2023 and bottomed at $2.0 million in Q3 2023.